Related Experiment Video
Updated: Jul 31, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Deficiency in mammalian STN1 promotes colon cancer development via inhibiting DNA repair
Dinh Duc Nguyen1, Eugene Kim1, Nhat Thong Le2
1Department of Cancer Biology, Cardinal Bernardin Cancer Center, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
Abstract:
Despite the high lethality of colorectal cancers (CRCs), only a limited number of genetic risk factors are identified. The mammalian ssDNA-binding protein complex CTC1-STN1-TEN1 protects genome stability, yet its role in tumorigenesis is unknown. Here, we show that attenuated CTC1/STN1 expression is common in CRCs. We generated an inducible STN1 knockout mouse model and found that STN1 deficiency in young adult mice increased CRC incidence, tumor size, and tumor load. CRC tumors exhibited enhanced proliferation, reduced apoptosis, and elevated DNA damage and replication stress. We found that STN1 deficiency down-regulated multiple DNA glycosylases, resulting in defective base excision repair (BER) and accumulation of oxidative damage. Collectively, this study identifies STN1 deficiency as a risk factor for CRC and implicates the previously unknown STN1-BER axis in protecting colon tissues from oxidative damage, therefore providing insights into the CRC tumor-suppressing mechanism.
Insights
STN1 deficiency is a newly identified risk factor for colorectal cancer (CRC). This study reveals the STN1-base excision repair (BER) pathway protects colon tissues from oxidative damage, offering insights into CRC suppression.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Colorectal cancers (CRCs) have high lethality with limited identified genetic risk factors.
- The CTC1-STN1-TEN1 complex is crucial for genome stability, but its role in cancer is unknown.
Purpose of the Study:
- To investigate the role of the CTC1-STN1-TEN1 complex, specifically STN1, in colorectal cancer development.
- To elucidate the molecular mechanisms by which STN1 deficiency contributes to CRC.
Main Methods:
- Generated an inducible STN1 knockout mouse model.
- Analyzed CRC tumors for proliferation, apoptosis, DNA damage, and replication stress markers.
- Assessed DNA glycosylase expression and base excision repair (BER) pathway function.
Main Results:
- Attenuated CTC1/STN1 expression was observed in CRCs.
- STN1 deficiency in mice led to increased CRC incidence, tumor size, and tumor load.
- STN1 deficiency caused enhanced proliferation, reduced apoptosis, elevated DNA damage, and replication stress.
- STN1 deficiency down-regulated DNA glycosylases, impairing BER and causing oxidative damage accumulation.
Conclusions:
- STN1 deficiency is identified as a risk factor for colorectal cancer.
- The STN1-BER axis is implicated in protecting colon tissues from oxidative damage.
- This study provides novel insights into the tumor-suppressing mechanisms of STN1 in CRC.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

